Profile data is unavailable for this security.
About the company
Nuo Therapeutics, Inc. is a commercial stage medical device company. The Company is focused on developing and marketing products for chronic wound care primarily within the United States. The Company commercializes cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing. The Company's product, Aurix, is a biodynamic hematogel that uses a patient's own platelets and plasma as a catalyst for healing. Its commercial offering consists of point of care technology for the separation of autologous blood to produce a platelet-based therapy for the chronic wound care market. This offering is known as Aurix or the Aurix System. The Aurix System produces a platelet rich plasma (PRP) gel at the point of care using the patient's own platelets and plasma sourced from a small draw of peripheral blood. Aurix comprises a natural, endogenous complement of protein and non-protein signal molecules that contribute to effective healing.
- Revenue in USD (TTM)782.01k
- Net income in USD-3.02m
- Incorporated1998
- Employees--
- LocationNuo Therapeutics Inc8285 EL RIO, SUITE 150HOUSTON 77054United StatesUSA
- Phone+1 (832) 236-9060
- Fax+1 (240) 499-2690
- Websitehttps://www.nuot.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Kintara Therapeutics Inc | 0.00 | -9.51m | 16.50m | 2.00 | -- | -- | -- | -- | -4.08 | -4.08 | 0.00 | 0.1071 | 0.00 | -- | -- | 0.00 | -131.55 | -220.94 | -185.60 | -329.97 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 40.24 | -- | 78.93 | -- |
AiXin Life International Inc | 4.19m | -2.16m | 16.52m | 207.00 | -- | -- | -- | 3.95 | -0.0866 | -0.0866 | 0.1675 | -0.0956 | 0.8147 | 4.68 | 10.31 | 20,225.36 | -42.12 | -16.93 | -- | -34.54 | 14.95 | 48.13 | -51.70 | -36.96 | 0.1701 | -- | -- | -- | 51.00 | 58.08 | 67.18 | -- | 194.59 | -- |
International Isotopes Inc. | 12.08m | -875.02k | 16.55m | 40.00 | -- | 4.09 | -- | 1.37 | -0.0017 | -0.0017 | 0.0233 | 0.0077 | 0.7303 | 5.96 | 8.30 | 302,058.00 | -5.29 | -0.1415 | -7.85 | -0.2401 | 61.78 | 57.42 | -7.24 | -0.2198 | 0.5733 | -3.77 | 0.3295 | -- | 9.71 | 3.42 | -386.58 | -- | 11.54 | -- |
Forte Biosciences Inc | 0.00 | -32.14m | 16.76m | 11.00 | -- | 0.5836 | -- | -- | -1.03 | -1.03 | 0.00 | 0.7882 | 0.00 | -- | -- | 0.00 | -93.54 | -72.06 | -104.30 | -82.27 | -- | -- | -- | -491,850.00 | -- | -- | 0.00 | -- | -- | -- | -126.79 | -- | -46.29 | -- |
Vincerx Pharma Inc | 0.00 | -38.25m | 16.95m | 42.00 | -- | -- | -- | -- | -1.79 | -1.79 | 0.00 | -0.029 | 0.00 | -- | -- | 0.00 | -130.68 | -- | -205.70 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 36.24 | -- | -- | -- |
Pharmacyte Biotech Inc | 0.00 | -14.82m | 17.16m | 2.00 | -- | 0.5513 | -- | -- | -1.64 | -1.64 | 0.00 | 5.74 | 0.00 | -- | -- | 0.00 | -1.53 | -13.35 | -1.62 | -13.70 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -1.81 | -- | -- | -- |
Nuo Therapeutics Inc | 782.01k | -3.02m | 17.59m | -- | -- | 51.74 | -- | 22.50 | -0.071 | -0.071 | 0.0183 | 0.0075 | 0.4516 | 0.7856 | 4.30 | -- | -174.64 | -116.16 | -294.62 | -354.84 | 78.74 | 70.02 | -386.76 | -854.53 | 1.01 | -1,418.93 | 0.00 | -- | 442.12 | -14.99 | 0.0095 | -- | -- | -- |
Aytu Biopharma Inc | 93.76m | -13.68m | 17.86m | 150.00 | -- | 0.5409 | -- | 0.1905 | -2.65 | -2.65 | 18.21 | 5.53 | 0.6792 | 2.42 | 2.93 | 625,053.30 | -9.91 | -33.56 | -25.58 | -52.81 | 65.32 | 56.89 | -14.60 | -73.81 | 0.6923 | 0.216 | 0.352 | -- | 11.10 | 96.56 | 84.33 | -- | -- | -- |
Ibio Inc | 50.00k | -17.13m | 18.02m | 26.00 | -- | 0.716 | -- | 360.47 | -13.10 | -17.09 | 0.0262 | 2.92 | 0.0011 | -- | 0.0065 | 1,923.08 | -36.24 | -28.09 | -67.39 | -32.63 | -- | -- | -34,258.00 | -1,467.30 | -- | -- | 0.3666 | -- | -100.00 | -- | 0.9764 | -- | 42.90 | -- |
Cara Therapeutics Inc | 16.94m | -122.54m | 18.11m | 55.00 | -- | 0.6075 | -- | 1.07 | -2.26 | -2.26 | 0.3118 | 0.5452 | 0.1392 | 1.34 | 4.35 | 307,963.60 | -100.70 | -35.76 | -115.83 | -40.82 | 75.18 | -- | -723.49 | -162.10 | 5.20 | -- | 0.00 | -- | -49.92 | 9.26 | -38.65 | -- | 100.66 | -- |
Synlogic Inc | 3.21m | -73.22m | 18.15m | 6.00 | -- | 1.35 | -- | 5.66 | -10.62 | -10.62 | 0.4576 | 1.15 | 0.0495 | -- | -- | 534,166.70 | -113.09 | -40.57 | -134.57 | -43.82 | -- | -- | -2,284.68 | -3,245.93 | -- | -- | 0.00008 | -- | 185.68 | 5.99 | 13.40 | -- | -48.05 | -- |
Lumos Pharma Inc | 1.53m | -37.13m | 18.18m | 33.00 | -- | 1.04 | -- | 11.92 | -4.59 | -4.59 | 0.1886 | 2.15 | 0.0332 | -- | 8.01 | 46,212.12 | -80.89 | -29.78 | -90.15 | -32.32 | -- | -- | -2,434.69 | -2,937.61 | -- | -- | 0.00 | -- | 34.67 | -30.31 | -9.57 | -- | -- | -- |
Sensei Biotherapeutics Inc | 0.00 | -31.92m | 18.28m | 27.00 | -- | 0.3126 | -- | -- | -1.20 | -1.20 | 0.00 | 2.33 | 0.00 | -- | -- | 0.00 | -36.55 | -47.03 | -39.39 | -54.33 | -- | -- | -- | -- | -- | -- | 0.0241 | -- | -- | -- | 29.82 | -- | 42.16 | -- |
VBI Vaccines Inc | 9.41m | -83.99m | 18.50m | 131.00 | -- | -- | -- | 1.97 | -6.93 | -6.93 | 0.4818 | -0.2166 | 0.0923 | 1.40 | 37.05 | 71,839.70 | -81.40 | -46.58 | -171.57 | -58.62 | -24.06 | -277.46 | -881.79 | -2,755.98 | 0.2116 | -1.60 | 1.13 | -- | 702.40 | 20.94 | 17.18 | -- | -32.07 | -- |
Indaptus Therapeutics Inc | 0.00 | -14.98m | 18.61m | 7.00 | -- | 1.99 | -- | -- | -1.78 | -1.78 | 0.00 | 1.10 | 0.00 | -- | -- | 0.00 | -87.86 | -66.55 | -97.46 | -81.23 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -7.68 | -- | -- | -- |
Polypid Ltd | 0.00 | -24.25m | 18.63m | 59.00 | -- | 2.61 | -- | -- | -12.35 | -12.35 | 0.00 | 1.49 | 0.00 | -- | -- | 0.00 | -84.94 | -76.92 | -120.03 | -89.61 | -- | -- | -- | -- | -- | -28.72 | 0.5498 | -- | -- | -- | 39.67 | -- | -42.34 | -- |
Holder | Shares | % Held |
---|---|---|
Deerfield Management Co. LPas of 15 Mar 2024 | 2.18m | 4.94% |
Ancora Family Wealth Advisors LLCas of 31 Mar 2024 | 4.70k | 0.01% |